Candel Therapeutics, Inc.
For the period ended Feb 19, 2026. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 19, 2026 · Filed Feb 19, 2026
Use the contents to explore the available documents and sections.
CADL$8.75+8.8%Stored close · as of Nov 6, 2026
Contents
(Exact name of Registrant as Specified in Its Charter)
| Delaware | 001-40629 | 52-2214851 |
|---|---|---|
| (State or Other Jurisdictionof Incorporation) | (Commission File Number) | (IRS EmployerIdentification No.) |
| 117 Kendrick StSuite 450 | ||
| Needham, Massachusetts | 02494 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Registrant’s Telephone Number, Including Area Code: (617) 916-5445
Not Applicable
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.